The suspension of trading in the securities of Imagion Biosystems Limited (‘IBX’) will be lifted immediately, following the release by IBX of an announcement regarding a proposed capital raising.
View the Reinstatement to Official Quotation announcement.
Imagion Initiates Manufacturing of MagSense® Drug for Phase 2 Clinical Study on HER2+ Breast Cancer
February 19, 2025
MELBOURNE – Imagion Biosystems (Company) (ASX : IBX), a company dedicated to improving healthcare outcomes through the early detection of cancer, is pleased to announce